top of page
Islets for US
KIDNEY TRANSPLANTATION STUDIES
Mercury- Living Donor Kidney Tx (with Bone Marrow)
A Phase 3 Prospective, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants
Funded by Medeor Therapeutics, Inc
A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis (FSGS) in de novo Kidney Transplant Recipients.
Funded by Astellas Pharma Global Development, Inc.
bottom of page